TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26975007

Group type: EXPERIMENTAL
Intervention: Gradual cessation (reduced smoking by 75% in 2 weeks before quitting)
Number of subjects: 697

Group type: COMPARATOR
Intervention: Abrupt cessation (quit smoking immediately)
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Gradual cessation
Number of subjects: 697

Group type: COMPARATOR
Intervention: Abrupt cessation
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Participants who preferred gradual cessation
Number of subjects: 697

Group type: COMPARATOR
Intervention: Participants who preferred abrupt cessation
Number of subjects: 697
Study: 24408211

Group type: EXPERIMENTAL
Intervention: 15 mg mCPP
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 30 mg mCPP
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 22266572

Group type: EXPERIMENTAL
Intervention: Ergocalciferol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 20222295

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 0
Study: 18848575

Group type: EXPERIMENTAL
Intervention: Point-light walker direction discrimination task
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Point-light walker identification task
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Eccentricity adjustment using F=1+E/E(2)
Number of subjects: 6
Study: 16115830

Group type: EXPERIMENTAL
Intervention: Patient held targets and self monitoring
Number of subjects: 441

Group type: COMPARATOR
Intervention: Usual care (blood pressure monitoring by practice)
Number of subjects: 441
Study: 12463426

Group type: EXPERIMENTAL
Intervention: Nasogastric decompression (n = 69)
Number of subjects: 136

Group type: COMPARATOR
Intervention: No nasogastric decompression (n = 67)
Number of subjects: 136
Study: 10526939

Group type: EXPERIMENTAL
Intervention: Nitrate infusion (isosorbide dinitrate: ISDN or nitroglycerin: TNG) for 30 minutes (group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrate infusion for 48 hours (group B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrate infusion for 78 hours (group C)
Number of subjects: 0
Study: 7481324

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy for high-risk tumors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined local treatment (surgery plus radiotherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single local modality (surgery or radiotherapy)
Number of subjects: 0
Study: 2261943

Group type: EXPERIMENTAL
Intervention: Enalapril (E)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Slow-release verapamil (V)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Enalapril (E) and Slow-release verapamil (V)
Number of subjects: 22
Study: 446311

Group type: EXPERIMENTAL
Intervention: Spiro‐Tablinen
Number of subjects: 6

Group type: COMPARATOR
Intervention: Aldactone‐100 Caps
Number of subjects: 6
Study: 31821466

Group type: EXPERIMENTAL
Intervention: Zinc bis-glycinate (15 mg elemental zinc), twice per day
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 31815647

Group type: EXPERIMENTAL
Intervention: Meat-based diet (900g/week of meat and derivatives)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Meat-based diet supplemented with alpha-tocopherol
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Pesco-vegetarian diet (450g/week of fish)
Number of subjects: 150

Group type: COMPARATOR
Intervention: All diets (meat-based, meat-based with alpha-tocopherol, pesco-vegetarian)
Number of subjects: 150
Study: 28640104

Group type: EXPERIMENTAL
Intervention: EasyTube (EzT)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 400
Study: 25888734

Group type: EXPERIMENTAL
Intervention: Play Streets
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control Streets
Number of subjects: 126
Study: 24007754

Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg given by mouth)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Simulated driving setting with Lorazepam
Number of subjects: 16
Study: 21311047

Group type: EXPERIMENTAL
Intervention: Health promotion intervention (patient education, health promotion coaching, medication management, physician care management)
Number of subjects: 452
Study: 19480559

Group type: EXPERIMENTAL
Intervention: Recombinant cytochromes P450 and physiologically based pharmacokinetic modelling
Number of subjects: 10
Study: 17826428

Group type: EXPERIMENTAL
Intervention: Cardiotocography + STAN analysis
Number of subjects: 799

Group type: COMPARATOR
Intervention: Cardiotocography
Number of subjects: 799
Study: 15102733

Group type: EXPERIMENTAL
Intervention: Extracorporeal membrane oxygenation (ECMO)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Incremental cost of neonatal ECMO
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Mean additional health service cost of neonatal ECMO
Number of subjects: 185
Study: 11072398

Group type: EXPERIMENTAL
Intervention: 21 mg/day nicotine patch
Number of subjects: 1039

Group type: EXPERIMENTAL
Intervention: 35 mg/day nicotine patch
Number of subjects: 1039

Group type: EXPERIMENTAL
Intervention: 42 mg/day nicotine patch
Number of subjects: 1039

Group type: COMPARATOR
Intervention: 0 mg/day nicotine patch (control)
Number of subjects: 1039
Study: 7564894

Group type: EXPERIMENTAL
Intervention: 6 mg caffeine/kg lean body mass
Number of subjects: 39

Group type: COMPARATOR
Intervention: No caffeine (control)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Caffeine ingestion
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Postmenopausal women with osteoporosis
Number of subjects: 39
Study: 2207419

Group type: EXPERIMENTAL
Intervention: Potassium 60 mmol/day alone
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Potassium 60 mmol/day in combination with magnesium 20 mmol/day
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 7461014

Group type: EXPERIMENTAL
Intervention: Loading dose of digoxin 1.25 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Loading dose of digoxin 0.625 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maintenance dose of digoxin 0.25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maintenance dose of digoxin 0.125 mg
Number of subjects: 0
Study: 31836261

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin 40UI
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 30199135

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 61
Study: 27888747

Group type: EXPERIMENTAL
Intervention: Exposure plus response prevention (E + RP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure plus safety behavior (E + SB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 25939742

Group type: EXPERIMENTAL
Intervention: Training in a transparent laparoscopic box trainer under direct vision followed by a standard non-transparent laparoscopic box trainer (Group 1)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Training in a standard laparoscopic box trainer (Group 2)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study: 24857519

Group type: EXPERIMENTAL
Intervention: LNAA tablets plus supplementation with tryptophan (Trp) and tyrosine (Tyr) tablets
Number of subjects: 10

Group type: COMPARATOR
Intervention: LNAA tablets plus placebo
Number of subjects: 10
Study: 23011591

Group type: EXPERIMENTAL
Intervention: Methylphenidate (20 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 19651265

Group type: EXPERIMENTAL
Intervention: Weight-bearing exercises
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Seated exercises
Number of subjects: 180

Group type: COMPARATOR
Intervention: Social visits
Number of subjects: 180
Study: 17616778

Group type: EXPERIMENTAL
Intervention: Entrée portion size of 500 g and energy density of 1.8 kcal/g
Number of subjects: 53

Group type: COMPARATOR
Intervention: Entrée portion size of 250 g and energy density of 1.3 kcal/g
Number of subjects: 53
Study: 15222514

Group type: EXPERIMENTAL
Intervention: Ibuprofen and combined technique of physical therapy
Number of subjects: 122

Group type: COMPARATOR
Intervention: Ibuprofen alone
Number of subjects: 122
Study: 11790931

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator (ICD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prophylactic ICD implantation
Number of subjects: 0
Study: 9849309

Group type: EXPERIMENTAL
Intervention: Standing radiographs
Number of subjects: 116

Group type: COMPARATOR
Intervention: Supine radiographs
Number of subjects: 116
Study: 7818632

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Computed Tomography (CT)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: MRI and plain spinal CT
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Angiography
Number of subjects: 156
Study: 31970512

Group type: EXPERIMENTAL
Intervention: Problem Management Plus (PM+)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-PM+ group (control)
Number of subjects: 80
Study: 30627841

Group type: EXPERIMENTAL
Intervention: Self-fixating mesh
Number of subjects: 270

Group type: COMPARATOR
Intervention: Non-fixating mesh
Number of subjects: 270
Study: 28069044

Group type: EXPERIMENTAL
Intervention: Active-acupuncture (TEAS)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo-acupuncture
Number of subjects: 142
Study: 25654309

Group type: EXPERIMENTAL
Intervention: Surgical LVR (n = 9)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Bronchoscopic LVR (n = 7)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham/unsuccessful bronchoscopic treatment (Control, n = 10)
Number of subjects: 26
Study: 24383720

Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Indacaterol 300 μg
Number of subjects: 563

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 563
Study: 22048783

Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 127
Study: 18841473

Group type: EXPERIMENTAL
Intervention: Psychoeducational booklet about stigma based on experiences of Black mental health consumers
Number of subjects: 42

Group type: COMPARATOR
Intervention: Existing brochures about services
Number of subjects: 42
Study: 17109595

Group type: EXPERIMENTAL
Intervention: Chromium picolinate (600 microg) and biotin (2 mg/day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 15701219

Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 432

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 432
Study: 11739451

Group type: EXPERIMENTAL
Intervention: Ghrelin infusion (0.1 microg/kg.min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 12
Study: 8988939

Group type: EXPERIMENTAL
Intervention: Special intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrient data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma cholesterol measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrient-biochemical relations
Number of subjects: 0
Study: 8477485

Group type: EXPERIMENTAL
Intervention: Diabetes education at a diabetes clinic with specific educational objectives.
Number of subjects: 2

Group type: COMPARATOR
Intervention: Conventional care at general medical clinics.
Number of subjects: 2
Study: 3557711

Group type: EXPERIMENTAL
Intervention: Nifedipine (15 micrograms/kg, intravenously)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Verapamil (0.1 mg/kg as a bolus followed by chronic infusion of 0.005 mg/kg/min for 3 min, intravenously)
Number of subjects: 26
Study: 29776990

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Phototherapy
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 27835980

Group type: EXPERIMENTAL
Intervention: Intervention: Community awareness raising, training and supervision of private sector providers, regular meetings between public and private providers.
Number of subjects: 8910

Group type: COMPARATOR
Intervention: Control: Standard care without the intervention components.
Number of subjects: 8910
Study: 25338053

Group type: EXPERIMENTAL
Intervention: Low-sodium, high-potassium salt substitute (65% sodium chloride, 25% potassium chloride, 10% magnesium sulfate)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Regular salt (100% sodium chloride)
Number of subjects: 282
Study: 22508203

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (1.5 μg/kg body weight)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Intravenous PCA with Piritramide
Number of subjects: 61
Study: 20723651

Group type: EXPERIMENTAL
Intervention: Candesartan 32 mg 1 time/day
Number of subjects: 114

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 114
Study: 18949661

Group type: COMPARATOR
Intervention: Cooling jacket for 40 min
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 30-min water immersion followed by a cooling jacket application for 40 min
Number of subjects: 6
Study: 15673877

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination of tramadol and morphine
Number of subjects: 90
Study: 12919771

Group type: EXPERIMENTAL
Intervention: Dronedarone 800 mg daily
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Dronedarone 1600 mg daily
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study: 10450290

Group type: EXPERIMENTAL
Intervention: Fruits and vegetables diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 0
Study: 8582994

Group type: EXPERIMENTAL
Intervention: Induced abortions
Number of subjects: 158

Group type: COMPARATOR
Intervention: Obstetric controls (no induced abortions)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Non-obstetric controls (no induced abortions)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Any induced abortions
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Two or more induced abortions
Number of subjects: 158
Study: 1940606

Group type: EXPERIMENTAL
Intervention: Positive-mood induction condition
Number of subjects: 50

Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 50
Study: 6261677

Group type: EXPERIMENTAL
Intervention: Prednisolone, starting dose 60 mg daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prednisolone, 10 mg/kg in rats
Number of subjects: 40
Study: 31712290

Group type: EXPERIMENTAL
Intervention: Community-links practitioner intervention (CLP)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Control group (comparison practices)
Number of subjects: 288
Study: 29975588

Group type: COMPARATOR
Intervention: Continuous exercise (CON)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intermittent exercise (INT)
Number of subjects: 12
Study: 27567017

Group type: EXPERIMENTAL
Intervention: 20-day computerized Listening and Communication Enhancement program
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: 10-day digital versatile disc Listening and Communication Enhancement program
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Placebo 'books-on-tape' training
Number of subjects: 263

Group type: COMPARATOR
Intervention: Educational counseling (active control)
Number of subjects: 263
Study: 25461963

Group type: EXPERIMENTAL
Intervention: Red-light-PDT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IPL-PDT
Number of subjects: 0

Group type: COMPARATOR
Intervention: IPL
Number of subjects: 0

Group type: COMPARATOR
Intervention: Red-light
Number of subjects: 0
Study: 23448083

Group type: EXPERIMENTAL
Intervention: Sonic powered toothbrush with unique sensing and control technologies
Number of subjects: 76

Group type: COMPARATOR
Intervention: Manual flat-trim toothbrush
Number of subjects: 76
Study: 21118875

Group type: EXPERIMENTAL
Intervention: Two doses of Edmonston‐Zagreb measles vaccine at 4.5 and 9 months of age (group A)
Number of subjects: 6648

Group type: COMPARATOR
Intervention: One dose of Edmonston‐Zagreb measles vaccine at 9 months of age (group B)
Number of subjects: 6648

Group type: COMPARATOR
Intervention: Schwarz measles vaccine at 9 months of age (group C)
Number of subjects: 6648
Study: 18084840

Group type: EXPERIMENTAL
Intervention: Loop diuretics
Number of subjects: 13
Study: 15076828

Group type: EXPERIMENTAL
Intervention: Phone interview
Number of subjects: 278

Group type: COMPARATOR
Intervention: Mail survey
Number of subjects: 278
Study: 11432684

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotic drugs
Number of subjects: 18585

Group type: COMPARATOR
Intervention: Conventional antipsychotic drugs
Number of subjects: 18585

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18585

Group type: EXPERIMENTAL
Intervention: Clozapine-treated groups
Number of subjects: 18585
Study: 9129531

Group type: EXPERIMENTAL
Intervention: EchiTab (one vial, 10 ml; 0.5 g protein)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Institute Pasteur Serum (Ipser) Africa antivenom (four ampules, 40 ml; 2.12 g protein)
Number of subjects: 7
Study: 8176008

Group type: EXPERIMENTAL
Intervention: Histologic evaluation by six dermatopathologists
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Histologic dysplasia correlation with nevus size
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Use of different diagnostic criteria for histologic dysplasia
Number of subjects: 149
Study: 3286518

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (250 mg/b.i.d.)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cefalexin (1 g/t.i.d.)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cefalexin-resistant bacterial strains (open study arm)
Number of subjects: 30
Study: 30219032

Group type: EXPERIMENTAL
Intervention: Physical and Cognitive Training (PTCT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Physical Training (PT)
Number of subjects: 100
Study: 27321604

Group type: EXPERIMENTAL
Intervention: Combined exercise group (n = 35) - two strength and two walking sessions
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Aerobic exercise group (n = 35) - four walking sessions
Number of subjects: 105

Group type: COMPARATOR
Intervention: Social control group (n = 35) - four nonexercise social visits per week
Number of subjects: 105
Study: 25381300

Group type: EXPERIMENTAL
Intervention: Bimagrumab
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 22541738

Group type: EXPERIMENTAL
Intervention: MedDiet + olive oil
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: MedDiet + nuts
Number of subjects: 785

Group type: COMPARATOR
Intervention: Control low-fat diet
Number of subjects: 785
Study: 20639624

Group type: EXPERIMENTAL
Intervention: Bisphosphonates (BPs) treatment
Number of subjects: 0
Study: 17850560

Group type: EXPERIMENTAL
Intervention: OPCAB
Number of subjects: 35

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 35
Study: 16212851

Group type: EXPERIMENTAL
Intervention: Guided self-help
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Anxiety Disorder Guidelines
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 154
Study: 12372131

Group type: EXPERIMENTAL
Intervention: FP 200 microg/day (constant dose group)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: FP 1000 microg/day with reductions to 500, 200 and 100 microg/day (stepdown group)
Number of subjects: 55
Study: 10669910

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ) with 300 mg of phenytoin (DPH)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Water with 300 mg of phenytoin (DPH)
Number of subjects: 20
Study: 8960728

Group type: EXPERIMENTAL
Intervention: High-dose interferon beta-1b (8.0 million units)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-dose interferon beta-1b (1.6 million units)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 2012909

Group type: EXPERIMENTAL
Intervention: Day-hospital treatment
Number of subjects: 86

Group type: COMPARATOR
Intervention: In-patient care
Number of subjects: 86
Study: 7044656

Group type: EXPERIMENTAL
Intervention: Attempted improved therapy (A group)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual therapy (U group)
Number of subjects: 74
Study: 30476269

Group type: EXPERIMENTAL
Intervention: Repetitive sleep restriction condition
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Recovery sleep (R2)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Recovery sleep (R2 and R3)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Baseline sleep
Number of subjects: 21
Study: 29183574

Group type: EXPERIMENTAL
Intervention: recombinant interleukin-1β (reIL-1β)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical biopsy technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimally invasive technique
Number of subjects: 0
Study: 26374297

Group type: EXPERIMENTAL
Intervention: Extended-release niacin/laropiprant (ERN/LRP)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 25401325

Group type: EXPERIMENTAL
Intervention: Enteric-coated aspirin 100 mg/d
Number of subjects: 14464

Group type: COMPARATOR
Intervention: No aspirin
Number of subjects: 14464
Study: 22833639

Group type: EXPERIMENTAL
Intervention: Posaconazole tablet 200 mg once daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Posaconazole tablet 200 mg twice daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Posaconazole tablet 400 mg once daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 19110026

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 43